FDA Inspection 1258278 — Jerome Bertherat
The FDA completed an inspection of Jerome Bertherat on Nov 29, 2024 in Paris. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 29, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Paris (France)
Additional Details
Clinical Investigator (CI)